The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
10x Genomics, Inc(NASDAQ:TXG) 
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluid...
Website: http://www.10xgenomics.com
Founded: 2012
IPO Price: $39 (Sep 12, 2019)
Full Time Employees: 1,243 (Dec 2022)
Founder: Serge Saxonov, Ben Hindson, Kevin Ness
CEO: Serge Saxonov
Sector: Healthcare
Industry: Health Information Services
10x Genomics Number of employees (headcount)
10x Genomics Days Payable Outstanding ttm (DPO)
10x Genomics Days Receivable Outstanding ttm (DSO)
10x Genomics Days Inventory Outstanding ttm (DIO)
10x Genomics Op Cashflow Per Share ttm
10x Genomics Free Cashflow Per Share ttm
10x Genomics Cash Per Share ttm
10x Genomics P/S ratio ttm
10x Genomics (GAAP) P/E ratio ttm
10x Genomics P/B ratio ttm
No extra charts and metrics for this ticker.